from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary: WINDTREE THERAPEUTICS INC /DE/ quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
WINDTREE THERAPEUTICS INC /DE/ Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $1,801,000, a 74% increase year-over-year.
WINDTREE THERAPEUTICS INC /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2024 was $12,733,000, a 9.8% increase from 2023.
WINDTREE THERAPEUTICS INC /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11,595,000, a 277% increase from 2022.
WINDTREE THERAPEUTICS INC /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $3,079,000, a 90% decline from 2021.
Source SEC data: View on sec.gov

Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Net Cash Provided by (Used in) Financing Activities, Annual (USD)

Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$1,801,000	+$767,000	+74%	01 Jan 2025	31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q1 2024	$1,034,000	+$443,000	+75%	01 Jan 2024	31 Mar 2024	10-Q	15 May 2025	2025	Q1
Q1 2023	$591,000	+$680,000		01 Jan 2023	31 Mar 2023	10-Q	15 May 2024	2024	Q1
Q1 2022	$89,000	-$27,697,000	-100%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q1 2021	$27,608,000	+$27,807,000		01 Jan 2021	31 Mar 2021	10-Q	05 May 2022	2022	Q1
Q1 2020	$199,000	+$399,000	+67%	01 Jan 2020	31 Mar 2020	10-Q	13 May 2021	2021	Q1
Q1 2019	$598,000	-$3,098,000	-124%	01 Jan 2019	31 Mar 2019	10-Q	13 May 2020	2020	Q1
Q1 2018	$2,500,000	-$7,286,000	-74%	01 Jan 2018	31 Mar 2018	10-Q	20 May 2019	2019	Q1
Q1 2017	$9,786,000			01 Jan 2017	31 Mar 2017	10-Q	21 May 2018	2018	Q1
Q1 2014	$435,000	-$9,398,000	-96%	01 Jan 2014	31 Mar 2014	10-Q	12 May 2014	2014	Q1
Q1 2013	$9,833,000	-$40,464,000	-80%	01 Jan 2013	31 Mar 2013	10-Q	12 May 2014	2014	Q1
Q1 2012	$50,297,000	+$27,751,000	+123%	01 Jan 2012	31 Mar 2012	10-Q	07 May 2013	2013	Q1
Q1 2011	$22,546,000			01 Jan 2011	31 Mar 2011	10-Q	15 May 2012	2012	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$12,733,000	+$1,138,000	+9.8%	01 Jan 2024	31 Dec 2024	10-K	15 Apr 2025	2024	FY
2023	$11,595,000	+$8,516,000	+277%	01 Jan 2023	31 Dec 2023	10-K	15 Apr 2025	2024	FY
2022	$3,079,000	-$26,282,000	-90%	01 Jan 2022	31 Dec 2022	10-K	16 Apr 2024	2023	FY
2021	$29,361,000	+$9,403,000	+47%	01 Jan 2021	31 Dec 2021	10-K	31 Mar 2023	2022	FY
2020	$19,958,000	-$1,810,000	-8.3%	01 Jan 2020	31 Dec 2020	10-K	31 Mar 2022	2021	FY
2019	$21,768,000	-$16,970,000	-44%	01 Jan 2019	31 Dec 2019	10-K	29 Mar 2021	2020	FY
2018	$38,738,000	+$21,442,000	+124%	01 Jan 2018	31 Dec 2018	10-K	03 Apr 2020	2019	FY
2017	$17,296,000	+$16,587,000	+2339%	01 Jan 2017	31 Dec 2017	10-K/A	23 Apr 2019	2018	FY
2016	$709,000			01 Jan 2016	31 Dec 2016	10-K	17 Apr 2018	2017	FY
2013	$100,453,000	+$50,230,000	+100%	01 Jan 2013	31 Dec 2013	10-K	17 Mar 2014	2013	FY
2012	$50,223,000	+$27,441,000	+120%	01 Jan 2012	31 Dec 2012	10-K	17 Mar 2014	2013	FY
2011	$22,782,000	+$3,941,000	+21%	01 Jan 2011	31 Dec 2011	10-K	17 Mar 2014	2013	FY
2010	$18,841,000			01 Jan 2010	31 Dec 2010	10-K	15 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.